Galderma (U.K) Ltd

Meridien House, 69-71 Clarendon Road, Watford, Hertfordshire, WD17 1DS, UK
Telephone: +44 (0)1923 208950
Fax: +44 (0)1923 208998
Medical Information e-mail: info.uk@galderma.com


Summary of Product Characteristics last updated on the eMC: 21/07/2010
SPC Calmurid Cream


Go to top of the page
1. NAME OF THE MEDICINAL PRODUCT

Calmurid 10%/5% w/w Cream


Go to top of the page
2. QUALITATIVE AND QUANTITATIVE COMPOSITION

One gram of cream contains 100 mg of Urea and 50 mg of Lactic acid

For a full list of excipients, see section 6.1


Go to top of the page
3. PHARMACEUTICAL FORM

Cream

A homogenous, white, oil-in-water cream


Go to top of the page
4. CLINICAL PARTICULARS

Go to top of the page
4.1 Therapeutic indications

To be applied topically for the correction of hyperkeratosis and dryness in ichthyosis and allied conditions characterised by dry, rough, scaly skin.


Go to top of the page
4.2 Posology and method of administration

For external use only.

Adults, elderly and children:

A thick layer of Calmurid is applied twice daily after washing the affected area. The cream is left on the skin for 3-5 minutes and then rubbed lightly in. Excess cream should be wiped off the skin with a tissue, not washed off. Frequency of application can be reduced as the patient progresses. In hyperkeratosis of the feet apply Calmurid as above after soaking the feet in warm water for 15 minutes and drying with a rough towel.


Go to top of the page
4.3 Contraindications

Hypersensitivity to the active substance or to any of the excipients


Go to top of the page
4.4 Special warnings and precautions for use

Calmurid is acidic and hypertonic and can cause smarting if applied to raw areas, fissures or mucous membranes. Where this is a barrier to therapy the use of Calmurid diluted 50% with aqueous cream B.P. for one week should result in freedom from smarting upon use of Calmurid.


Go to top of the page
4.5 Interaction with other medicinal products and other forms of interaction

Low pH of cream might affect stability of other drugs.


Go to top of the page
4.6 Pregnancy and lactation

There is no specific data available regarding the use in pregnant women and during lactation.


Go to top of the page
4.7 Effects on ability to drive and use machines

Calmurid has no or negligible influence on the ability to drive and use machines.


Go to top of the page
4.8 Undesirable effects

Calmurid is acidic and hypertonic and can cause smarting if applied to raw areas, fissures or mucous membranes.


Go to top of the page
4.9 Overdose

Unlikely. In the case of smarting, wash the cream off.


Go to top of the page
5. PHARMACOLOGICAL PROPERTIES

Go to top of the page
5.1 Pharmacodynamic properties

Pharmacotherapeutic group: Carbomide products

ATC code: D02AE

Urea at a concentration of 10% has keratolytic, anti microbial, anti pruritic and hydrating effects on the skin. Lactic acid has keratolytic, hydrating and anti microbial properties also. Treatment of ichthyotic patients shows a parallel between clinical improvement and increase in the otherwise depressed binding capacity of the horny layer.


Go to top of the page
5.2 Pharmacokinetic properties

Not applicable.


Go to top of the page
5.3 Preclinical safety data

There are no preclinical data of relevance to the prescriber, which are additional to those already included in other sections of the SmPC


Go to top of the page
6. PHARMACEUTICAL PARTICULARS

Go to top of the page
6.1 List of excipients

Glyceryl Monostearate

Betaine Monohydrate

Diethanolamine Cetylphosphate (``Amphisol'')

Hard Fat

Cholesterol

Sodium chloride

Purified water


Go to top of the page
6.2 Incompatibilities

The low pH due to lactic acid means care in choice of other packages or other drugs admixed.


Go to top of the page
6.3 Shelf life

24 months.


Go to top of the page
6.4 Special precautions for storage

Do not store above 25°C. Do not refrigerate or freeze.


Go to top of the page
6.5 Nature and contents of container

Tubes

White low density polyethylene tubes fitted with white polypropylene screw caps

Package sizes: 15, 20, 30, 50, 100 g.

Pump dispenser

White polypropylene bottle fitted with a white polyethylene closure and a natural polyethylene follower plate.

Package sizes: 400, 500 g.

Not all pack sizes may be marketed.


Go to top of the page
6.6 Special precautions for disposal and other handling

Not relevant.


Go to top of the page
7. MARKETING AUTHORISATION HOLDER

Galderma (UK) Limited

Meridien House

69-71 Clarendon Road

Watford

Herts.

WD17 1DS

UK


Go to top of the page
8. MARKETING AUTHORISATION NUMBER(S)

PL 10590/0009


Go to top of the page
9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION

9 February 1993


Go to top of the page
10. DATE OF REVISION OF THE TEXT

December 2008



More information about this product

Link to this document from your website: http://www.medicines.org.uk/emc/medicine/689/SPC/


Active Ingredients/Generics

 
   urea
   lactic acid